References and Notes
1
Jochims JC. In
Comprehensive Heterocyclic Chemistry II
Vol. 4:
Katritzky AR.
Rees CW.
Scriven EVF.
Pergamon Press;
London:
1996.
Chap. 4.
p.179-228 ; and references therein
2
Clapp LB.
Adv. Heterocycl. Chem.
1976,
20:
65
3
Vu CB.
Corpuz EG.
Merry TJ.
Pradeepan SG.
Bartlett C.
Bohacek RS.
Botfield MC.
Lynch BA.
MacNeil IA.
Ram MK.
van Schravendijk MR.
Violette S.
Sawyer TK.
J. Med. Chem.
1999,
42:
4088
4a
Bezerra NMM.
De Oliveira SP.
Srivastava RM.
Da Silva JR.
Il Farmaco
2005,
60:
955
4b
Diana GD.
Volkots DL.
Hitz TJ.
Bailey TR.
Long MA.
Vescio N.
Aldous S.
Pevear DC.
Dutko FJ.
J. Med. Chem.
1994,
37:
2421
4c
Swain CJ.
Baker R.
Kneen C.
Moseley J.
Saunders J.
Seward EM.
Stevenson G.
Beer M.
Stanton J.
Watling KJ.
J. Med. Chem.
1991,
34:
140
4d
Orlek BS.
Blaney FE.
Brown F.
Clark MSG.
Hadley MS.
Hatcher J.
Riley GJ.
Rosenberg HE.
Wadsworth HJ.
Wyman PJ.
J. Med. Chem.
1991,
34:
2726
4e
Watjen F.
Baker R.
Engelstoff M.
Herbert R.
Macleod A.
Knight A.
Merchant K.
Moseley J.
Saunder J.
Swain CJ.
Wong E.
Springer JP.
J. Med. Chem.
1989,
32:
2282
4f
Ankersen M.
Peschke B.
Hansen BS.
Hansen TK.
Bioorg. Med. Chem. Lett.
1997,
7:
1293
5 Hagen H, and Becke F. inventors; Ger. Offen. DE 2,060,082.
; Chem. Abstr. 1972, 77, 88511
6
Torgova SI.
Karamysheva LA.
Geivandova TA.
Strigazzi A.
Mol. Cryst. Liq. Cryst. Sci. Technol., Sect. A
2001,
365:
99
7a
Wang Y.
Miller RL.
Sauer DR.
Djuric SW.
Org. Lett.
2005,
7:
925
7b
Evans MD.
Ring J.
Schoen A.
Bell A.
Edwards P.
Berthelot D.
Nicewonger R.
Baldino CM.
Tetrahedron Lett.
2003,
44:
9337
7c
Kaboudin B.
Navaee K.
Heterocycles
2003,
60:
2287
8
Microwaves in Organic Synthesis
2nd reprint:
Loupy A.
Wiley-VCH;
Weinheim:
2004.
9 The experiments were performed using a microwave oven (ETHOS 1600, Milestone) with a power of 600 W specially designed for organic synthesis.
10a
Clarke K.
J. Chem. Soc.
1954,
4251
10b
Srivastava RM.
Mendes e Silva LM.
J. Chem. Eng. Data
1984,
29:
221
10c
Young TE.
Beidler WT.
J. Org. Chem.
1985,
50:
1182
10d
Chiou S.
Shine HJ.
J. Heterocycl. Chem.
1989,
26:
125
11
Preparation of 5-Methyl-3-phenyl-1,2,4-oxadiazole (
5a); General Procedure.
A mixture of benzonitrile (0.21 g, 2 mmol), NH2OH 50% (0.13 g, 2 mmol), and a catalytic amount of AcOH was irradiated with microwaves at 100 °C for 1 min. After nearly complete conversion to the corresponding amidoxime as was indicated by TLC, Meldrum’s acid (0.29 g, 2 mmol) was added to the reaction mixture and it was irradiated at 150 °C for a further 2 min. After cooling to r.t., the solid residue was sublimated and 5a obtained as colorless crystals. In the case of the products 5d-h, the obtained crude solid were purified by recrystallization from 95% EtOH, and the products 5b,c,i-n were purified by column chromatography (4:1 n-hexane-EtOAc as eluent, Merck silica gel 60 mesh).
Selected Data.
Compound 5a: colorless crystals. 1H NMR (500.1 MHz, CDCl3): δ = 2.60 (3 H, s, CH3), 7.45 (3 H, m, 3 × CH), 8.04 (2 H, dd, J = 7.8 Hz and J = 1.7 Hz, 2 × CH). 13C NMR (125.8 MHz, CDCl3): δ = 12.30 (CH3), 124.01 (C), 127.32, 128.80, and 131.05 (3 × CH), 168.38 (NCN), 176.29 (NCO).
Compound 5d: colorless crystals. 1H NMR (500.1 MHz, CDCl3): δ = 2.36 (3 H, s, PhCH3), 2.58 (3 H, s, CH3), 7.23 (2 H, d, J = 7.8 Hz, 2 × CH), 7.92 (2 H, d, J = 7.8 Hz, 2 × CH). 13C NMR (125.8 MHz, CDCl3): δ = 12.25 (CH3), 21.44 (PhCH3), 124.00 (C), 127.21 and 129.48 (2 × CH), 141.31 (C), 168.32 (NCN), 176.27 (NCO).
Compound 5e: colorless crystals. 1H NMR (500.1 MHz, CDCl3): δ = 2.62 (3 H, s, CH3), 7.37 (1 H, t, J = 7.9 Hz, CH), 7.43 (1 H, dd, J = 8.1 Hz and J = 1.1 Hz, CH), 7.91 (1 H, d, J = 7.7 Hz, CH), 8.03 (1 H, s, CH). 13C NMR (125.8 MHz, CDCl3): δ = 12.30 (CH3), 125.36 and 127.45 (2 × CH), 128.58 (C), 130.11 and 131.09 (2 × CH), 134.92 (C), 167.41 (NCN), 176.78 (NCO).
Compound 5j: colorless oil. 1H NMR (500.1 MHz, CDCl3): δ = 1.40 (3 H, t, J = 7.6 Hz, CH2CH
3), 2.35 (3 H, s, CH3), 2.91 (2 H, q, J = 7.6 Hz, CH2), 7.22 (2 H, d, J = 8.0 Hz, 2 × CH), 7.92 (2 H, d, J = 8.0 Hz, 2 × CH). 13C NMR (125.8 MHz, CDCl3): δ = 10.78 (CH2
CH3), 20.27 (CH2), 21.45 (PhCH3), 124.21 (C), 127.29 and 129.48 (2 × CH), 141.26 (C), 168.22 (NCN), 180.51 (NCO).
Compound 5l: colorless crystals. 1H NMR (500.1 MHz, CDCl3): δ = 1.42 (3 H, t, J = 7.6 Hz, CH3), 2.94 (2 H, q, J = 7.6 Hz, CH2), 7.42 (2 H, d, J = 8.5 Hz, 2 × CH), 7.98 (2 H, d, J = 8.5 Hz, 2 × CH). 13C NMR (125.8 MHz, CDCl3): δ = 10.78 (CH3), 20.30 (CH2), 125.51 (C), 128.69 and 129.11 (2 × CH), 137.15 (C), 167.46 (NCN), 180.91 (NCO).
Compound 5n: colorless crystals. 1H NMR (500.1 MHz, CDCl3): δ = 1.44 (3 H, t, J = 7.6 Hz, CH3), 2.97 (2 H, q, J = 7.6 Hz, CH2), 7.60 (2 H, d, J = 8.5 Hz, 2 × CH), 7.94 (2 H, d, J = 8.5 Hz, 2 × CH). 13C NMR (125.8 MHz, CDCl3): δ = 10.81 (CH3), 20.33 (CH2), 125.59 and 125.98 (2 × C), 128.91 and 132.11 (2 × CH), 167.59 (NCN), 180.98 (NCO).